Published in Arch Ophthalmol on February 01, 2002
Development of toxic anterior segment syndrome immediately after uneventful phaco surgery. Korean J Ophthalmol (2008) 0.78
Toxic anterior segment syndrome after pediatric cataract surgery. J AAPOS (2010) 0.75
Toxic anterior-segment syndrome (TASS). Clin Ophthalmol (2014) 0.75
Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med (2011) 19.42
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology (2012) 11.91
Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol (2008) 3.14
Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology (2013) 2.82
Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol (2002) 2.20
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology (2012) 2.19
Utility of intraoperative optical coherence tomography during vitrectomy surgery for vitreomacular traction syndrome. Retina (2014) 2.15
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database Syst Rev (2014) 1.95
Interface fluid syndrome in human eye bank corneas after LASIK: causes and pathogenesis. Ophthalmology (2007) 1.89
Increased endothelial cell density in the paracentral and peripheral regions of the human cornea. Am J Ophthalmol (2003) 1.79
Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology (2012) 1.70
Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea (2008) 1.68
Ocular drug delivery. Expert Opin Drug Deliv (2006) 1.61
Depth-dependent cohesive tensile strength in human donor corneas: implications for refractive surgery. J Refract Surg (2008) 1.58
Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. Ophthalmology (2013) 1.57
Toxic anterior segment syndrome. J Cataract Refract Surg (2006) 1.53
Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA). Invest Ophthalmol Vis Sci (2009) 1.41
Evaluation of endothelial mucin layer thickness after phacoemulsification with next generation ophthalmic irrigating solution. Cornea (2008) 1.39
Pathological findings in eyes with the ganciclovir implant. Ophthalmology (2005) 1.38
Cohesive tensile strength of human LASIK wounds with histologic, ultrastructural, and clinical correlations. J Refract Surg (2005) 1.33
Neuroprotective effect of subretinal implants in the RCS rat. Invest Ophthalmol Vis Sci (2005) 1.27
Corneal ectasia after excimer laser keratorefractive surgery: histopathology, ultrastructure, and pathophysiology. Ophthalmology (2008) 1.22
Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res (2010) 1.20
Histologic, ultrastructural, and immunofluorescent evaluation of human laser-assisted in situ keratomileusis corneal wounds. Arch Ophthalmol (2005) 1.18
Biomechanical and wound healing characteristics of corneas after excimer laser keratorefractive surgery: is there a difference between advanced surface ablation and sub-Bowman's keratomileusis? J Refract Surg (2008) 1.17
Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Ophthalmology (2005) 1.16
Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Mol Vis (2008) 1.15
A novel segmentation algorithm for volumetric analysis of macular hole boundaries identified with optical coherence tomography. Invest Ophthalmol Vis Sci (2013) 1.13
Evidence suggesting the existence of stem cells for the human corneal endothelium. Mol Vis (2005) 1.12
Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis. Ophthalmology (2004) 1.11
Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas. Mol Vis (2007) 1.10
Long-term histopathologic findings in human corneal wounds after refractive surgical procedures. Am J Ophthalmol (2005) 1.08
Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci (2012) 1.07
Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res (2008) 1.07
Antibody blockade of junctional adhesion molecule-A in rabbit corneal endothelial tight junctions produces corneal swelling. Invest Ophthalmol Vis Sci (2006) 1.06
Multistate outbreak of toxic anterior segment syndrome, 2005. J Cataract Refract Surg (2008) 1.06
Three cases of large retinal capillary hemangiomas treated with verteporfin and photodynamic therapy. Arch Ophthalmol (2005) 1.06
Retinal function after subconjunctival injection of carboplatin in fibrin sealant. Retina (2004) 1.05
Enzymatic detergents and toxic anterior segment syndrome. Ophthalmology (2013) 1.05
Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry. Invest Ophthalmol Vis Sci (2007) 1.05
Coated microneedles for drug delivery to the eye. Invest Ophthalmol Vis Sci (2007) 1.04
Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. J Refract Surg (2007) 1.01
Influence of dosage form on the intravitreal pharmacokinetics of diclofenac. Invest Ophthalmol Vis Sci (2009) 1.00
Retracted Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models. Invest Ophthalmol Vis Sci (2011) 1.00
Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin). Retina (2009) 0.99
Barriers to glaucoma drug delivery. J Glaucoma (2008) 0.99
A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. Invest Ophthalmol Vis Sci (2006) 0.98
Modeling of corneal and retinal pharmacokinetics after periocular drug administration. Invest Ophthalmol Vis Sci (2008) 0.98
Ex vivo confocal microscopy of human LASIK corneas with histologic and ultrastructural correlation. Ophthalmology (2005) 0.98
Transscleral diffusion of carboplatin: an in vitro and in vivo study. Arch Ophthalmol (2002) 0.96
Interface fluid syndrome in laser in situ keratomileusis after complicated trabeculectomy. J Cataract Refract Surg (2006) 0.96
Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems. Exp Eye Res (2004) 0.95
Expression of JAM-A in the human corneal endothelium and retinal pigment epithelium: localization and evidence for role in barrier function. Invest Ophthalmol Vis Sci (2007) 0.95
Anatomic alterations in aging and age-related diseases of the eye. Invest Ophthalmol Vis Sci (2013) 0.94
In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system. J Ocul Pharmacol Ther (2002) 0.94
Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci (2008) 0.93
Drug and gene delivery to the back of the eye: from bench to bedside. Invest Ophthalmol Vis Sci (2014) 0.93
VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT). JAMA Ophthalmol (2014) 0.92
Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant. Am J Ophthalmol (2003) 0.92
Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye. Adv Healthc Mater (2014) 0.92
Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes. Mol Vis (2013) 0.91
Pegaptanib sodium. Nat Rev Drug Discov (2005) 0.90
Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial. Arch Ophthalmol (2008) 0.89
In vitro sustained human transscleral drug delivery of fluorescein-labeled dexamethasone and methotrexate with fibrin sealant. Curr Eye Res (2005) 0.89
Epstein-barr infection of the retina: case report and review of the literature. Retin Cases Brief Rep (2011) 0.88
Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time. Invest Ophthalmol Vis Sci (2008) 0.88
Histologic and ultrastructural findings in human corneas after successful laser in situ keratomileusis. Arch Ophthalmol (2002) 0.87
Aging changes of mouse corneal endothelium and Descemet's membrane. Exp Eye Res (2006) 0.87
Retinal translocation and photodynamic therapy for age-related macular degeneration with classic choroidal neovascularization: a clinicopathologic case report. Retina (2002) 0.87
Recommended practices for cleaning and sterilizing intraocular surgical instruments. J Cataract Refract Surg (2007) 0.85
Outbreak of toxic anterior segment syndrome following cataract surgery associated with impurities in autoclave steam moisture. Infect Control Hosp Epidemiol (2006) 0.85
Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. Retina (2004) 0.85
Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials. Ophthalmology (2013) 0.84
Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes. Invest Ophthalmol Vis Sci (2008) 0.84
Emergence of drug-resistant cytomegalovirus retinitis in the contralateral eyes of patients with AIDS treated with ganciclovir. J Infect Dis (2004) 0.84
Histopathological analysis of post-laser-assisted in situ keratomileusis corneal ectasia with intrastromal corneal ring segments. Arch Ophthalmol (2005) 0.83
The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds. Invest Ophthalmol Vis Sci (2005) 0.83
Endophthalmitis after ganciclovir implant in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol (2003) 0.82
Proposed new classification scheme for chemical injury to the human eye. Regul Toxicol Pharmacol (2006) 0.82
Viscoelastic protection from endothelial damage by air bubbles. J Cataract Refract Surg (2002) 0.82
Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide. Int J Pharm (2012) 0.81
Scleral permeability of a small, single-stranded oligonucleotide. J Ocul Pharmacol Ther (2004) 0.81
A comparison of static near stereo acuity in youth baseball/softball players and non-ball players. Optometry (2009) 0.81
In vivo ocular fluorophotometry: delivery of fluoresceinated dextrans via transscleral diffusion in rabbits. Invest Ophthalmol Vis Sci (2011) 0.81
Human scleral diffusion of anticancer drugs from solution and nanoparticle formulation. Pharm Res (2009) 0.81
Incidence of postvitrectomy macular edema using optical coherence tomography. Ophthalmology (2009) 0.80
Trans-tamponade optical coherence tomography: postoperative imaging in gas-filled eyes. Retina (2013) 0.80
Corneal epithelial testing strategies for safety evaluation of ophthalmic formulations. Cutan Ocul Toxicol (2007) 0.80
Measurement and prediction of lateral diffusion within human sclera. Invest Ophthalmol Vis Sci (2006) 0.80
Nationwide outbreak of red eye syndrome associated with transfusion of leukocyte-reduced red blood cell units. Infect Control Hosp Epidemiol (2006) 0.80
Chronic pain after Intacs implantation. J Cataract Refract Surg (2006) 0.79
Correlation between epithelial ingrowth and basement membrane remodeling in human corneas after laser-assisted in situ keratomileusis. Arch Ophthalmol (2010) 0.79
Transscleral permeability of fluorescent-labeled antibiotics. J Ocul Pharmacol Ther (2005) 0.79
The disposition and bioavailability of 35S-GSH from 35S-GSSG in BSS PLUS in rabbit ocular tissues. J Ocul Pharmacol Ther (2004) 0.79
Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix. J Control Release (2003) 0.78
Corneal endothelium after refractive surgery. J Cataract Refract Surg (2011) 0.78
Keratan sulfate and chondroitin/dermatan sulfate in maximally recovered hypocellular stromal interface scars of postmortem human LASIK corneas. Invest Ophthalmol Vis Sci (2006) 0.78
Mucoadhesive microparticles in a rapidly dissolving tablet for sustained drug delivery to the eye. Invest Ophthalmol Vis Sci (2011) 0.78
Shortage of bisulfite-free preservative-free epinephrine for intracameral use. J Cataract Refract Surg (2011) 0.77